MedTrace Logo

Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease

NCT02422238 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-09-13

No results posted yet for this study

Summary

The aim of the present prospective NAFLD cohort study (with biobank), of obese subjects with proven NAFLD based on liver biopsy and/or MRI, is to study factors contributing to the development of NASH in patients with simple steatosis and to identify and validate non-invasive markers for the diagnosis of NASH.

Conditions

  • Nonalcoholic Fatty Liver Disease

Sponsors & Collaborators

  • Centrum Obesitas-Eetstoornissen (CO-EUR)

    collaborator UNKNOWN

  • Maastricht University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-12-31
Completion
2027-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02422238 on ClinicalTrials.gov